Concepedia

Thomas M. Lancaster

TM

Statistics

Publications

4

Citations

102

H-Index

4

Active since

2021

Affiliations

Akston Biosciences (United States)(Current)

Baylor College of Medicine

University of California, Davis

Texas Children's Hospital

University Medical Center Groningen

Thomas M. Lancaster is an author at Akston Biosciences (United States) specializing in vaccinology, immunization, and vaccine immunology.

ORCID

Publications per year

2021–2023

4

Publications

4

Development of an IgG-Fc fusion COVID-19 subunit vaccine, AKS-452

David G. Alleva, Andrea R. Delpero, Melanie Scully et al. · Vaccine · 2021 · 45 citations · Full text

, , +17

Ultra-long-acting recombinant insulin for the treatment of diabetes mellitus in dogs

Sean E. Hulsebosch, Jully Pires, Michael J. Bannasch et al. · Journal of Veterinary Internal Medicine · 2022 · 24 citations · Full text

, , +16

Phase I interim results of a phase I/II study of the IgG-Fc fusion COVID-19 subunit vaccine, AKS-452

Yester F. Janssen, Eline A. Feitsma, Hendrikus H. Boersma et al. · Vaccine · 2022 · 17 citations · Full text

, , +17

A randomized phase I/II safety and immunogenicity study of the Montanide-adjuvanted SARS-CoV-2 spike protein-RBD-Fc vaccine, AKS-452

Eline A. Feitsma, Yester F. Janssen, Hendrikus H. Boersma et al. · Vaccine · 2023 · 16 citations · Full text

, , +17

1–4 of 4